跳至主要内容
临床试验/KCT0002260
KCT0002260招募中未知

Hospital-based Diabetes Prevention Study in Korea ; A Prospective, Multi-center, Randomized, Open-label Controlled study

Kyung Hee University Hospital0 个研究点目标入组 744 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
744

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
31(Year) 至 64(Year)(—)
性别
All

入选标准

  • 1. 30<Age<65
  • 2. BMI=23 kg/m2
  • 3. '75g OGTT: 140~199 mg/dL' or 'Fasting Blood Sugar 110~125' 'HbA1c 5.7%~6.4%'

排除标准

  • 1. Who diagnosed with Diabetes Mellitus or Who having Drugs for Diabetes Mellitus.
  • 2. Type 2 Dibetes Mellitus
  • ? Who diagnosed with Diabetes Mellitus except for maternity period.
  • ? Who have had drugs for Diabetes Mellitus(hypoglycemic agent or insulin) except for maternity period.
  • ? Fasting Glucose= 126 mg/dL
  • ? 2 hours after 75g OGTT = 200 mg/dL
  • ? HbA1c = 6.5%
  • 3. Who life expectancy is short.
  • ? Cardiac history
  • ?- History of severe cardiovascular disease within the last 6 months (cerebral hemorrhage, stroke, myocardial infarction, angina pectoris, heart failure, etc.)
  • ?- Systolic blood pressure >180 mmHg or Diastolic blood pressure >105 mmHg
  • ?- aortic stenosis
  • ?- Left bundle branch block or Third degree AV block
  • ? Who had been diagnosed and treated for malignant tumors including leukemia and lymphoma within the last 5 years
  • ? Abnormal renal function (Creatinine = 1.4 mg/dL (male) or = 1.3 mg/dL (female) or Urine Protein = 2 +)
  • ? Anemia(Hematocrit <36%((male) or><33%(female)) ? Cirrhosis or chronic active hepatitis (AST/ALT>3UNL)
  • ? Acute gastrointestinal disease (pancreatitis, infectious intestinal disease)
  • ? Who is scheduled major surgery within the last 3 to 6 months or just after the surgery.
  • ? Chronic infection (HIV, active tuberculosis, etc.)
  • ? Pulmonary patients who rely on oxygen or daily bronchodilators
  • 4. Who is judged to be able to influence the clinical trial by investigator.
  • ? Who can not communicate
  • ? Those with psychiatric or cognitive impairment that may affect the compliance of the clinical trial
  • ? Those who do not agree to the treatment group allocation by random assignment
  • ? Those who participate in other studies that may interfere with the clinical trial
  • ? Those who lost weight by more than 10% during the past 6 months, excluding weight loss after giving birth
  • ? Those who can not have normal walking or exercise
  • ? Women who are pregnant
  • ? Those who are currently pregnant or who are within the last 3 months after giving birth
  • ? Those planning pregnancy during the clinical trial period
  • ? Those who have a history of drug and alcohol abuse (acute, chronic) within the last 2 years
  • ? Those who are not appropriate or unreliable for clinical trials at the discretion of the tester
  • 5.Who taking medication or medical condition that may affect the diagnosis of diabetes
  • ? Thiazide diuretics
  • ? Systemic beta blockers
  • ? Taking Niacinfor the treatment of neutropenic depression
  • ? Possibility of taking or injecting a systemic steroid preparation
  • ? Taking a serotonin reuptake inhibitor (SSRI) for weight loss purpose.
  • ? Taking medicine for weight loss
  • ? Hormone status is not appropriate during thyroid hormone replacement therapy (TSH abnormal range)
  • (If thyroid hormone therapy is stable for more than 3 months and TSH is normal, the patient can participate in)
  • ? Others with other endocrine diseases (eg Cushing's syndrome, acromegaly)
  • ? During treatment, fasting plasma triglyceride> 600 mg / d

研究者

发起方
Kyung Hee University Hospital

相似试验